- Memorial Sloan-Kettering Cancer Center in Commack recently unveiled a new body imaging device, known as a PET/CT scanner. Not too many other cancer treatment centers on Long Island carry this scanner.
- Researchers at Memorial Sloan-Kettering Cancer Center have found that change in PSA levels over time (known as PSA velocity) is a poor predictor of prostate cancer and may lead to many unnecessary biopsies. Andrew Vickers, PhD, Associate Attending Research Methodologist in the Department of Epidemiology and Biostatistics and Peter T. Scardino, MD, Chair of the Department of Surgery are quoted in this article.
- New Research and Training Grants Awarded By American Cancer Society Emily Tonorezos, MD MPH at Memorial Sloan-Kettering Cancer Center received a career development award that will give her the time and the tools to investigate diet and insulin resistance in survivors of childhood cancer. (Cancer Survivorship Grant)
- MRI Found to Improve Breast Cancer Detection Rate. Janice S. Sung, MD, from the Memorial Sloan-Kettering Cancer Center in New York City, and colleagues evaluated the utility of MR imaging in detection of breast cancer in 91 women with a history of chest irradiation.
Category Archives: MSK in the News
MSKCC in the News: March 9 – March 23
- In a recent Nature article, MSKCC researchers in collaboration with researchers from several other institutions offered a genetic explanation for why people with lung cancer respond differently to erlotinib.
- James P. Allison, head of the immunology program at MSKCC, was quoted in a New York Times article about the recent FDA approved drug Yervoy, the first drug shown to prolong the lives of people with the skin cancer melanoma.
MSKCC in the News: February 23 – March 9
- Dr. Moritz Kircher of MSKCC is quoted in an article published by the U.S. News & World Report about the development of a microchip that can be attached to a smart phone and used to diagnose cancerous tumors within an hour.
- Andrew Vickers of MSKCC, the lead author of a study that concluded that using PSA velocity for prostate cancer detection is ineffective, that it leads to unnecessary biopsies and that references to it should be removed from professional guidelines and policy statements, recently commented in a New York Times article that there is no direct connection between PSA velocity and prostate cancer.
- In a Time article, Dr. Marc Gollub of MSKCC commented on a study that found that use of virtual colonoscopy, a non-invasive way of scanning the colon for potentially cancerous growths, is on the rise.